Molecular control of Acinetobacter baumannii biofilm development and persistence
DOI:
https://doi.org/10.15343/0104-7809.202650e20492026IKeywords:
Quorum Sensing, Bacterial Fimbriae, Cross Infection, Drug Tolerance, Virulence FactorsAbstract
Acinetobacter baumannii is a critical nosocomial pathogen whose persistence is closely linked to biofilm-associated survival. This narrative review critically examined structural determinants, regulatory networks, evidence strength, and intervention points across the biofilm lifecycle. Reproducible targeted searches of PubMed, Scopus, and Web of Science used no lower date limit and were last conducted in April 2026, prioritizing mechanistic, structural, clinical-isolate, and in vivo evidence. The literature supports a context-dependent network in which Csu pili, Ata, and OmpA interact with BfmRS, quorum sensing, cyclic di-GMP, LeuO, and matrix-export systems. The review distinguishes genetically inherited antimicrobial resistance from reversible biofilm-associated tolerance and persistence, identifies strain- and model-dependent controversies, and maps anti-adhesion, signaling, matrix, phage, and anti-persister strategies. Because most interventions remain preclinical, biofilm control may benefit from stage-specific combinations whose penetration, toxicity, stability, and resistance risk are evaluated in clinically relevant models.
Downloads
Translations of this article
References
Ayobami O, Brinkwirth S, Eckmanns T, Markwart R. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infect. 2022;11(1):443-451. DOI: 10.1080/22221751.2022.2030196
Sharma S, et al. Reservoir of carbapenem-resistant Acinetobacter baumannii in the hospital environment and colonization pressure: a surveillance-based study in Indian intensive care unit. Microb Drug Resist. 2022;28(12):1079-1086. DOI: 10.1089/mdr.2022.0088
Lee CR, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55. DOI: 10.3389/fcimb.2017.00055
Ciofu O, Moser C, Jensen PO, Høiby N. Tolerance and resistance of microbial biofilms. Nat Rev Microbiol. 2022;20(10):621-635. DOI: 10.1038/ s41579-022-00682-4
Upmanyu K, Haq QMR, Singh R. Factors mediating Acinetobacter baumannii biofilm formation: opportunities for developing therapeutics. Curr Res Microb Sci. 2022;3:100131. DOI: 10.1016/j.crmicr.2022.100131
Mendes SG, Combo SI, Allain T, Domingues S, Buret AG, Da Silva GJ. Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies. Eur J Clin Microbiol Infect Dis. 2023;42(12):1405-1423. DOI: 10.1007/s10096-023-04677-8
Shenkutie AM, Yao MZ, Siu GKH, Wong BKC, Leung PHM. Biofilm-induced antibiotic resistance in clinical Acinetobacter baumannii isolates. Antibiotics (Basel). 2020;9(11):817. DOI: 10.3390/antibiotics9110817
Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology. 2008;154(11):3398-3409. DOI: 10.1099/mic.0.2008/019471-0
Palethorpe S, et al. Acinetobacter baumannii regulates its stress responses via the BfmRS two-component regulatory system. J Bacteriol. 2022;204(2):e00494-21. DOI: 10.1128/jb.00494-21
Geisinger E, Mortman NJ, Vargas-Cuebas G, Tai AK, Isberg RR. A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. PLoS Pathog. 2018;14(5):e1007030. DOI: 10.1371/journal.ppat.1007030
Shenkutie AM, Gebrelibanos D, Yao M, Hundie GB, Chow FWN, Leung PHM. Impairment of novel non-coding small RNA00203 inhibits biofilm formation and reduces biofilm-specific antibiotic resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 2023;62(3):106889. DOI: 10.1016/j. ijantimicag.2023.106889
Hamrock FJ, et al. Global analysis of the RNA-RNA interactome in Acinetobacter baumannii AB5075 uncovers a small regulatory RNA repressing the virulence-related outer membrane protein CarO. Nucleic Acids Res. 2024;52(18):11283-11300. DOI: 10.1093/nar/gkae668
Ahmad I, et al. Csu pili dependent biofilm formation and virulence of Acinetobacter baumannii. npj Biofilms Microbiomes. 2023;9(1):101. DOI: 10.1038/s41522-023-00465-6
Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149(12):3473-3484. DOI: 10.1099/mic.0.26541-0
Pakharukova N, et al. Structural basis for Acinetobacter baumannii biofilm formation. Proc Natl Acad Sci U S A. 2018;115(21):5558-5563. DOI: 10.1073/pnas.1800961115
Malmi H, et al. Antiparallel stacking of Csu pili drives Acinetobacter baumannii 3D biofilm assembly. Nat Commun. 2026;17(1):2508. DOI: 10.1038/ s41467-026-68860-z
Brychcy M, Nguyen B, Tierney GA, Casula P, Kokodynski A, Godoy VG. The metabolite vanillic acid regulates Acinetobacter baumannii surface attachment. Mol Microbiol. 2024;121(5):833-849. DOI: 10.1111/mmi.15234
Tram G, Poole J, Adams FG, Jennings MP, Eijkelkamp BA, Atack JM. The Acinetobacter baumannii autotransporter adhesin Ata recognizes host glycans as high-affinity receptors. ACS Infect Dis. 2021;7(8):2352-2361. DOI: 10.1021/acsinfecdis.1c00021
Bentancor LV, Camacho-Peiro A, Bozkurt-Guzel C, Pier GB, Maira-Litran T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. J Bacteriol. 2012;194(15):3950-3960. DOI: 10.1128/JB.06769-11
Weidensdorfer M, et al. The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii. Virulence. 2019;10(1):68-81. DOI: 10.1080/21505594.2018.1558693
Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun. 2009;77(8):3150-3160. DOI: 10.1128/IAI.00096-09
Liao C, et al. Human neutrophil alpha-defensin HNP1 interacts with bacterial OmpA to promote Acinetobacter baumannii biofilm formation. Nat Commun. 2025;16(1):5629. DOI: 10.1038/s41467-025-60935-7
Kim HJ, et al. Complementary regulation of BfmRS two-component and AbaIR quorum sensing systems to express virulence-associated genes in Acinetobacter baumannii. Int J Mol Sci. 2022;23(21):13136. DOI: 10.3390/ijms232113136
Mayer C, et al. Quorum sensing as a target for controlling surface associated motility and biofilm formation in Acinetobacter baumannii ATCC 17978TM. Front Microbiol. 2020;11:565548. DOI: 10.3389/fmicb.2020.565548
Lopez-Martin M, Dubern JF, Alexander MR, Williams P. AbaM regulates quorum sensing, biofilm formation, and virulence in Acinetobacter baumannii. J Bacteriol. 2021;203(8):e00635-20. DOI: 10.1128/JB.00635-20
Romero M, et al. Mushroom-shaped structures formed in Acinetobacter baumannii biofilms grown in a roller bioreactor are associated with quorum sensing-dependent Csu-pilus assembly. Environ Microbiol. 2022;24(9):4329-4339. DOI: 10.1111/1462-2920.15985
Pumirat P, et al. Impact of AbaI mutation on virulence, biofilm development, and antibiotic susceptibility in Acinetobacter baumannii. Sci Rep. 2024;14(1):21521. DOI: 10.1038/s41598-024-72740-1
Ahmad I, Nygren E, Khalid F, Myint SL, Uhlin BE. A cyclic-di-GMP signalling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978. Sci Rep. 2020;10(1):1991. DOI: 10.1038/s41598-020-58522-5
de Dios R, et al. Network-level divergence in cyclic di-GMP signalling drives ecological versatility in Acinetobacter baumannii. npj Biofilms Microbiomes. 2026;12(1):112. DOI: 10.1038/s41522-026-00968-y
Islam MM, Kim K, Lee JC, Shin M. LeuO, a LysR-type transcriptional regulator, is involved in biofilm formation and virulence of Acinetobacter baumannii. Front Cell Infect Microbiol. 2021;11:738706. DOI: 10.3389/fcimb.2021.738706
Tiwari M, Panwar S, Kothidar A, Tiwari V. Rational targeting of Wzb phosphatase and Wzc kinase interaction inhibits extracellular polysaccharides synthesis and biofilm formation in Acinetobacter baumannii. Carbohydr Res. 2020;492:108025. DOI: 10.1016/j.carres.2020.108025
Mushtaq F, et al. Colony phase variation switch modulates antimicrobial tolerance and biofilm formation in Acinetobacter baumannii. Microbiol Spectr. 2024;12(2):e02956-23. DOI: 10.1128/spectrum.02956-23
Armalyte J, et al. A polyamine acetyltransferase regulates the motility and biofilm formation of Acinetobacter baumannii. Nat Commun. 2023;14(1):3531. DOI: 10.1038/s41467-023-39316-5
Thavorasak T, et al. CRISPR/Cas9-targeted smpB mutation revealing roles in biofilm formation, motility, and antibiotic susceptibility in Acinetobacter baumannii. PLoS One. 2025;20(8):e0329638. DOI: 10.1371/journal.pone.0329638
Rastegar S, et al. Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii. BMC Infect Dis. 2024;24(1):1208. DOI: 10.1186/s12879-024-10081-0
Barati H, Fekrirad Z, Jalali Nadoushan M, Rasooli I. Anti-OmpA antibodies as potential inhibitors of Acinetobacter baumannii biofilm formation, adherence to, and proliferation in A549 human alveolar epithelial cells. Microb Pathog. 2024;186:106473. DOI: 10.1016/j.micpath.2023.106473
Sharma S, Tiwari V. Autophagy modulation by OmpA-targeted lead compounds restores autophagic flux, reduces biofilm, and enhances immune response in Acinetobacter baumannii-infected pulmonary cells. Microbiol Spectr. 2026;14(7):e00036-26. DOI: 10.1128/spectrum.00036-26
Acharya K, Borborah S, Chatterjee A, Ghosh M, Bhattacharya A. A comprehensive profiling of quorum quenching by bacterial pigments identifies quorum sensing inhibition and antibiofilm action of prodigiosin against Acinetobacter baumannii. Arch Microbiol. 2023;205(12):364. DOI: 10.1007/ s00203-023-03710-w
Rajapaksha DC, Edirisinghe SL, Nikapitiya C, Whang I, De Zoysa M. The antimicrobial peptide octopromycin suppresses biofilm formation and quorum sensing in Acinetobacter baumannii. Antibiotics (Basel). 2023;12(3):623. DOI: 10.3390/antibiotics12030623
Chines E, Boscarelli L, Vertillo Aluisio G, Santagati M, Mezzatesta ML, Cafiso V. Deciphering the emergence of biofilm-independent colistin persistence and resistance in A. baumannii: toxin-antitoxin omics and novel T/A mRNA-asRNA balance regulatory models. Antibiotics (Basel). 2026;15(4):337. DOI: 10.3390/antibiotics15040337
Latifi F, Hashemi A, Kalani BS, Pakzad I, Hematian A. abkBA toxin-antitoxin system may act as antipersister modules in Acinetobacter baumannii clinical isolates. Future Microbiol. 2023;18(11):707-714. DOI: 10.2217/fmb-2022-0271
Elbehiry A, et al. Understanding Pseudomonas aeruginosa biofilms: quorum sensing, c-di-GMP signaling, and emerging antibiofilm approaches. Microorganisms. 2026;14(1):109. DOI: 10.3390/microorganisms14010109
Peng Q, Tang X, Dong W, Sun N, Yuan W. A review of biofilm formation of Staphylococcus aureus and its regulation mechanism. Antibiotics (Basel). 2023;12(1):12. DOI: 10.3390/antibiotics12010012
Garomsa TL, Shenkutie AM, Leung PHM. Recent advances in host models in studying virulence factors and pathogenesis of Acinetobacter baumannii. Front Cell Infect Microbiol. 2025;15:1715193. DOI: 10.3389/fcimb.2025.1715193
Jackson-Litteken CD, et al. A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections. Nat Commun. 2025;16(1):7617. DOI: 10.1038/s41467-025-62655-4
Tagueha AD, et al. A decade of genomic and phenotypic adaptation of carbapenem-resistant Acinetobacter baumannii. Front Cell Infect Microbiol. 2025;15:1527488. DOI: 10.3389/fcimb.2025.1527488
Kishii K, et al. Differences in biofilm formation and transcription of biofilm-associated genes among Acinetobacter baumannii clinical strains belonging to the international clone II lineage. J Infect Chemother. 2020;26(7):693-698. DOI: 10.1016/j.jiac.2020.02.017
Orozco-Ochoa AK, et al. Pangenomics of high-risk international clones in Acinetobacter baumannii identifies distinctive virulence and antimicrobial resistance profiles. Arch Microbiol. 2026;208(4):173. DOI: 10.1007/s00203-026-04738-4
Elanany AA, Khalifa AG, Attia AS. Antivirulence drugs against Acinetobacter baumannii: where do they stand? World J Microbiol Biotechnol. 2025;41(11):424. DOI: 10.1007/s11274-025-04593-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 O Mundo da Saúde

This work is licensed under a Creative Commons Attribution 4.0 International License.




























